Chemotherapy with Gemcitabine in Advanced Biliary Tract Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|3|1|70-78

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.3, Iss.1, 2008-01, pp. : 70-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma

By  

Chemotherapy, Vol. 56, Iss. 3, 2010-06 ,pp. : 234-238

Karger

Access to resources Recommend Favorite

Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine

By Sasaki Takashi  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 708-713

Springer Publishing Company

Access to resources Recommend Favorite

Prospective Phase II Trial of Gemcitabine in Combination with Irinotecan as First-Line Chemotherapy in Patients with Advanced Biliary Tract Cancer

By  

Chemotherapy, Vol. 57, Iss. 3, 2011-05 ,pp. : 236-243

Karger

Access to resources Recommend Favorite

Chemotherapy with Gemcitabine and Oxaliplatin in Patients with Advanced Biliary Tract Cancer: A Single-Institution Experience

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 311-315

Karger

Access to resources Recommend Favorite

Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer:A Retrospective Study

By  

Case Reports in Oncology, Vol. 3, Iss. 3, 2010-12 ,pp. : 498-504

Karger

Access to resources Recommend Favorite